<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study aimed to ascertain the potential of Centratherum anthelminticum seeds methanolic fraction (CAMFs) for the management of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and its associated complications </plain></SENT>
<SENT sid="1" pm="."><plain>CAMFs was initially tested on β-TC6 cells for <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi>-induced nuclear factor-κB (NF-κB) translocation effects </plain></SENT>
<SENT sid="2" pm="."><plain>The result displayed that CAMFs significantly inhibited NF-κB translocation from cytoplasm into the nucleus, dose-dependently </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, a 12-week sub-<z:hpo ids='HP_0011010'>chronic</z:hpo> CAMFs study was carried out on <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> (STZ)-<z:chebi fb="0" ids="17154">nicotinamide</z:chebi>-induced type 2 diabetic rat model to evaluate glycemia, essential biochemical parameters, <z:chebi fb="23" ids="18059">lipid</z:chebi> levels, <z:mp ids='MP_0003674'>oxidative stress</z:mp> markers, and pro-inflammatory cytokines level </plain></SENT>
<SENT sid="4" pm="."><plain>Our study result showed that CAMFs reduced <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> by increasing serum insulin, C-<z:chebi fb="7" ids="16670">peptide</z:chebi>, total protein, and albumin levels, significantly </plain></SENT>
<SENT sid="5" pm="."><plain>Whereas, elevated blood <z:chebi fb="105" ids="17234">glucose</z:chebi>, glycated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, <z:chebi fb="23" ids="18059">lipids</z:chebi> and enzyme activities were restored to near <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>CAMFs confirmed <z:chebi fb="11" ids="22586">antioxidant</z:chebi> potential by elevating <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) and reducing malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>) levels in diabetic rats </plain></SENT>
<SENT sid="7" pm="."><plain>Interestingly, CAMFs down-regulated elevated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor α (TNF-α), interleukin (IL)-1β and IL-6 in the tissues and serum of the diabetic rats </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that CAMFs exerted apparent <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> effects and demonstrated as a valuable candidate <z:chebi fb="0" ids="50733">nutraceutical</z:chebi> for insulin-resistant type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and its associated complications such as <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>